Pharma Trends in 2020

Pharma Trends in 2020

Every pharmaceutical company is talking about patient engagement. A greater focus on the patient gives way to valuable real-world data and insight into therapy performance and medication adherence. Pharmaceutical companies want to understand how patients respond to therapies to ultimately improve health outcomes.

Improved commercial strategies and models require access to better data. Unifying data across provider, patient, and partner information on a common platform gives all stakeholders a single view into valuable operational and customer insights.

Services that go “beyond the pill” help bolster revenue growth, especially in the face of drug patent expirations, generics, and biosimilar products entering the market.

Read more here.

About the author

Dr. Mariana Damova is the CEO of Mozaika, a company providing research and solutions in the field of data science, reasoning with natural language semantics, and natural human computer interfaces, creativity enhancing applications, and research infrastructures for the humanities. Previously, she was a Business development Manager and a Knowledge Management Expert specializing in ontology engineering and linked data management at a world leading technology provider. She was instrumental in the successful winning and knowledge modelling of large data integration and management projects such as the Semantic Knowledge Base for The National Archive of the United Kingdom and Research Space for the British Museum, as well as European FP7 projects such as Europeana Creative and Multisensor. Her work focuses on the design and development of data integration infrastructures which allow efficient querying, access and navigation over linked data. She has managed the building of the official experimental Europeana SPARQL endpoint holding Europeana semantic data. Mariana holds a PhD from the University of Stuttgart and teaches semantic technologies and multimedia at the New Bulgarian University in Sofia. She regularly reviews books and articles for ACM and has authored books and scientific articles in linguistics and semantic technologies. She has successfully lead international interdisciplinary teams and projects carrying technological risks, driven and managed change in engineering and operational contexts in North America and in Europe, and acquired the ability to leverage marketing requirements with knowledge intense technological solutions.

No comments

Leave a Reply

Your email address will not be published. Required fields are marked *